Xcout Intel
GRO Biosciences Inc.
GRO Biosciences Inc. is an emerging biotechnology company headquartered in Cambridge, Massachusetts. The company leverages groundbreaking science to expand the amino acid alphabet and deliver on the promise of advanced protein therapeutics.
Subscribe to see GRO Biosciences Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
GRO Biosciences Inc. at a glance
GRO Biosciences Inc. is a healthcare company headquartered in United States. Its most recent funding round raised $27.4M in July 2024. Xcout tracks 3 named people at GRO Biosciences Inc., including Daniel J. Mandell (Chief Executive Officer).
GRO Biosciences Inc. leadership
- Daniel J. MandellChief Executive Officer
- Christopher J. Gregg, PhDChief Science Officer
- Jürgen Eckhardt, MD, MBAHeads of Leaps by Bayer
GRO Biosciences Inc. funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $27.4M | — | |
| Series B | $60.3M | 12 named | |
| Series A | $25M | 12 named | |
| SEC Form D filing | $3.7M | — | |
| Seed | $2.1M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
GRO Biosciences Inc. competitors
A few of GRO Biosciences Inc.'s closest competitors — see the full list of competitors and alternatives →
Constructive Bio is a biotechnology research company headquartered in Cambridge, United Kingdom, that focuses on designing and manufacturing proteins with non-canonical amino acids for new medicines and materials.
Nabla Bio is a biotechnology company headquartered in Cambridge, Massachusetts. It develops protein engineering platforms and technical solutions.
Exo Therapeutics is a small molecule drug discovery and development biotechnology company headquartered in Cambridge, Massachusetts. The company utilizes a pioneering proprietary technology platform to unlock and address notoriously intractable pharmaceutical and disease targets.
Expedition Medicines, Inc. is a biotechnology company founded in 2022 and headquartered in Cambridge, Massachusetts, focused on generatively designing novel drugs targeting specific proteins.
Senda Biosciences is a biotechnology company focused on harnessing nature to program novel medicines, headquartered in Cambridge, Massachusetts.
ProFound Therapeutics is a biotechnology company founded in 2020 at Flagship Labs, a unit of Flagship Pioneering. Headquartered in Cambridge, Massachusetts, the company is pioneering the exploration of the expanded human proteome.
Get GRO Biosciences Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on GRO Biosciences Inc. in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 5 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access